1-Methylpiperazine → HCID 131723007, compound
Reaction equation
[CH3:1][O:2][C:3]1[C:4](=[O:29])[C:5]2[CH2:6][CH:7]([CH2:15][CH2:16][CH2:17][CH2:18][O:19][C:20]3[CH:28]=[CH:27][C:23]([C:24]([OH:26])=O)=[CH:22][CH:21]=3)[CH2:8][C:9]=2[C:10](=[O:14])[C:11]=1[O:12][CH3:13].[CH3:30][N:31]1[CH2:36][CH2:35][NH:34][CH2:33][CH2:32]1.Cl.C(N=C=NCCCN(C)C)C.O.ON1C2C=CC=CC=2N=N1>O.C(N(CC)CC)C>[CH3:13][O:12][C:11]1[C:10](=[O:14])[C:9]2[CH2:8][CH:7]([CH2:15][CH2:16][CH2:17][CH2:18][O:19][C:20]3[CH:21]=[CH:22][C:23]([C:24]([N:34]4[CH2:35][CH2:36][N:31]([CH3:30])[CH2:32][CH2:33]4)=[O:26])=[CH:27][CH:28]=3)[CH2:6][C:5]=2[C:4](=[O:29])[C:3]=1[O:2][CH3:1]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 4-[4-(5,6-dimethoxy-4,7-dioxoindan-2-yl)butoxy]benzoic acid (500 mg), 1-methylpiperazine (250 mg), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (479 mg), 1-hydroxybenzotriazole monohydrate (383 mg), triethylamine (0.697 ml), andTHF (20 ml) was stirred at room temperature for 10 hr. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was washed with water and saturated aqueous sodium chloride and dried. The solvent was removed in vacuo. The residue was purified by alumina column chromatography (ethyl acetate) and then with recrystallization from ethyl acetate-diisopropylether to yield the entitled compound (297 mg) as crystals.
Workup
- extractionextracted with ethyl acetate
- washThe organic layer was washed with water and saturated aqueous sodium chloride
- customdried
- customThe solvent was removed in vacuo
- customThe residue was purified by alumina column chromatography (ethyl acetate)
- customwith recrystallization from ethyl acetate-diisopropylether
Sources & evidence
- ORD record
- ord-8c8bbb5bd7884fa8863c763204db3211
- Source dataset
- uspto-grants-2001_12
- Patent number
- US06326369B1
Reaction notes
Loading…